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\bstracts
Introduction: Il.vpertension is one o{'the main risk I'actors fbr the development and
--,''gression ol.heart lailure. rn1'ocardial inf-arction (MI) and Stroke. Renovascular hypertension
: rrre of the major types ol'secondar,v hlrpertension. T'hese patients are prone to resistance to
. rod pressure reclucing drugs. Apelin clccreaseci the artcrial pressure in hyperlension including
'--:ovascular hypertensior-r. As apelin/APJ svstcm inr,'oil'es in the regulation of blood
'r'.'ssure/myocardial contractility. it is not surprising that the apelin/APJ systen-r plays direct and
...Jirect roles on the function of the heart. Apelin receptors (APJ) cross-talk w'ith other G-protein-
- -Lplecl receptors such as kappa opioid receptors (KORst on ph,vsiologic functior-rs. Apelin has
-.,srtrve cardiac inotropic elfects through protein kinase C (PKC) activation and phosphorylation
- ERKi/2 and the heterodimerization of APJ and KORs increases PKC activation and
.',sphor)'lation of ERKli2 in response to apelin. The role of interaction between opioid and
::lin reccptors on cardiovascular ef'fects of apelin uas not knowr. Therefbre. the present study
.rccl at evaluating the heterodimerization betu,een KOR ancl APJ and assessing the impact of
', ancl high closes o1' apelin on the lel'el of heterodimerization in the myocardium in
- -,\i:lsclllar ir1-perter-rsion. In addition. as the role'ol EIIKli2 phosphorylation and PKC in
::iatir-rg the ctrrdiac intpacts of apelin in rats rvith renovascular hypertension and the role of
..1 receptors (OPRs) in this regard is unclear. the rolc of these intracellular n"rediators. the
- . .:ssior-r of KORs. and tl-re role of intcraction betlveen OPRs ancl APJ on the cardiovascular
- -:JlS of apelin in a chronic renor,'ascular rnodel of hypertension was also investigated.
\lethods: Erperiments nere carried oLlt on 168 Wistar rats u'eighing 170- 200 grams. For
-,,..trn of chror-ric 2K1C hy'pertension. after ar"reslhesia rvith ketamine and xylazine a 0.2-ntn.t
. , 
.:,;'r pleriulas clip was placed on the leI1 kidney arter,v. The animals were divided into tu'entl'
- -:-,'.rps n'ith 8 rats in each. At the end of week 16. afier anesthesia with sodium thiopental.
'-:.r catireters tllled rlith heparin saline r,r,ere placed in right femoral afier)', left r'entricle 1L-\'1
., ,r :ire jugular r.ein tbr recording hemodl'namic anci cardiac contractility incidences and iniection
lhe drugs respectivelv. 'l'he artery anc'l vcrrtricular cannulas rvere connected to pressure
-'-.rsducers and then to an 8-channel Pou.erlab svstem.
. .3A (an APJ antagonist), naloxone (a general OPR inhibitor). nor-BNI (a selective inhibitor of
iOR) and chelervthrine (PKC inhibitor) were given IV l0 rr-rin prior to injectior-rs of apelin at
ioses of 40 and 60 pLgr'kg. PTX (Goi inhibitor) was in-jected intra-peritoneally' 48 hours prior to
ihe hemod-vnamic experiments. 'l'he heteroclimerization of KOR and APJ. the expression of KOR
ntRNA and protein in the lefi ventricle of 2KlC rats wcre measurred b.v immunoprecipitation.
nestern blot and. real time PC|R respectivell'. 'fhe levels of ERK1/2 phosphorylation n'ere
r'r'aluated by F.l-l SA.
Results: The arterial s1'stolic/diastolic blood pressure in sham and 2K1C rats w'as 110/71 mmHg
,.rtd 171/124 nrrnHg. respecti\elr'. The h1'potensive ef-fects ol.apelin at both doses were inhibited
:r F134 and naloxone. Nor-BNI completel.v inhibited the ellbcts of apelin 40 on arterialpresslrre.
.,nd decreasecl the eI-lects at 60 pg/kg. Apelir-i ,10 ar-rd 60 decreased blood presslrre through Gi
:athway. Apelin 60 also rcduced blood pressure through PKC pathw'a.v. Apelin in both doses
.ncreased cardiac contractility. The cardiaic impacts in both closes w'ere reduced by F'13A.
:',rlorone. nor-LINI ancl cl-relerl'trine and blockeci b1, P'fX. KORs inhibition and chelerl,trine also
:revented the compensation fbr the decrease in tl.re left ventricie +dp/dt max and 
-dp/dt max
,.tr"tsed b1' apelin 60. 'l'iic sirnultaneous inhibitii>r.i ol'OPR and APJ and KORs ar"rcl APJ reduced
-,r'terial pressure anc'l increased cardiac contracttlitf in response to apelin 60. Hl,pertension
.:creased the expression of KOI{s and heteroclimerization of APJ and KOR. and reduced ERKl/2
.. t1-ie lefi ventricle. Apelin. in both doses reducecl the level of heterodimerization in 2K1C animals
,::td recoverec'l the reduction in pERKI/2. Inhibition ol KORs significantll,increased ERKI/2
ion in response to apelin 60pg/kg, Chelerythrine ii-rhibited apelin 40 and 60- indLrced
60- induced increase in ERKI/2in [:RK1/2 phosphorllation. I']'l'X inhibited apelin
iation.
Conclutions: Findings showed that the OPR. particr-rlarly KOR, mediate the inotropic.
..itropic. ar.rd depressor eflects of- apelin. 'fhe interaction of the OPR and APJ augments the
-.,-,tropic and r,'asodcpressor cfl'ccts of apelin. 2K1C hy,pertension increased the expression of
:.ORs and heterodin-rerization of APJ and KORs. 'l'he heterodirnerization r.l'as associated by'
.-.luctiorr of ERK phosphorl'lation and alterecl the cardiac inotropic and lusitropic efl'ects o1'
,, relin. I'hese changes ma)'par"ticipate in pathopliysiologl,of cardiac dysfunction in renovascuiar
.',pertension that is irssociatecl u'ith subnorn-al lcvcl ol'scrlur apelin. Apelin- induced recov-er!"
, ERKl/2 phosphory'lation and KOR-APJ dirnerization may nominate apelin as a therapeutic
--,rl ir-r trcatnrent o1-this kincl of h.vpertension.
